Roundtable 1: Plasmid Strategy in 2026 & Beyond: Speed, Quality, or Flexibility-Do You Still Have to Choose?

Roundtable 1: Plasmid Strategy in 2026 & Beyond: Speed, Quality, or Flexibility-Do You Still Have to Choose?

Only 1 seat left
Tuesday, March 17, 2026 12:30 PM to 1:30 PM · 1 hr. (Europe/London)
Keynote (Keynote Theatre)
Roundtable Discussion
Bionova Scientific16Bionova Scientific is a bespoke CDMO providing end-to-end development and GMP manufacturing services for recombinant proteins and plasmid DNA. We support biotherapeutic programs at any stage, from cell line development through commercial-ready manufacturing. Protein operations are based in Fremont, California, with a dedicated plasmid DNA facility in Houston, Texas offering plasmid design through GMP production. Founded in 2014 and acquired by Asahi Kasei in 2022, Bionova combines CDMO agility with the global resources and financial strength of a leading bioprocessing organization.

Log in

See all the content and easy-to-use features by logging in or registering!